introduct
issu
highlight
research
present
nation
foundat
infecti
diseas
annual
confer
vaccin
research
vaccin
repres
one
success
public
health
measur
histori
develop
led
complet
elimin
human
diseas
ever
erad
smallpox
well
erad
one
three
polio
serotyp
unit
state
alon
routin
immun
children
vaccin
diseas
estim
prevent
million
case
diseas
birth
cohort
along
avert
death
howev
develop
safe
effect
vaccin
requir
mani
remain
infecti
diseas
vaccin
avail
well
counter
unexpect
emerg
new
deadli
pathogen
remain
mani
area
exist
vaccin
suboptim
effect
safeti
characterist
may
improv
upon
moreov
vaccin
underutil
intervent
need
improv
uptak
nation
foundat
infecti
diseas
nfid
establish
long
histori
educ
public
healthcar
profession
caus
prevent
treatment
infecti
diseas
midlat
dr
greg
poland
bill
marton
len
novick
senior
leader
nfid
put
forth
propos
nfid
board
truste
format
new
confer
goal
creat
scientif
forum
bring
togeth
divers
distinct
disciplin
constitut
vaccinolog
vaccin
focus
confer
would
design
address
key
challeng
optim
prevent
treatment
diseas
vaccin
would
bring
togeth
scientist
public
health
offici
philanthrop
nongovernment
organ
industri
healthcar
practition
develop
concept
pursu
discuss
among
individu
rang
small
larg
extern
organ
among
dr
vaccin
polici
optim
use
minim
diseas
burden
thu
distinct
research
meet
narrowli
focus
specif
antigen
narrow
diseas
target
vaccinolog
topic
receiv
narrow
focu
part
limit
session
larg
infectiousdiseas
congress
sinc
iter
acvr
give
person
interest
vaccinolog
outstand
opportun
hear
world
expert
field
present
work
interact
colleagu
potenti
develop
enhanc
collabor
sever
major
featur
defin
meet
primari
goal
welcom
paper
diseas
target
research
issu
order
encourag
crossfertil
commun
among
research
develop
divers
vaccin
upstream
middl
downstream
end
proverbi
vaccin
pipelin
anoth
distinguish
featur
semididact
natur
fulli
half
confer
alloc
usual
six
plenari
symposia
three
four
expert
deliv
invit
present
broad
rang
time
specif
topic
select
plan
committe
vari
year
year
tabl
remain
half
time
devot
concurr
oral
session
compris
paper
select
planningcommitte
review
unsolicit
abstract
submit
confer
attende
accept
poster
viewabl
throughout
three
day
acvr
featur
particip
major
address
preemin
vaccinologist
thu
provid
environ
young
research
interact
lead
pioneer
scientist
field
focu
crossgener
interact
reinforc
confer
award
meet
earlycar
young
investig
sponsor
merck
honor
dr
mauric
hilleman
well
lifetim
achiev
vaccinolog
sponsor
sanofi
pasteur
honor
dr
charl
also
usual
venu
award
albert
b
sabin
vaccin
institut
gold
medal
extraordinari
contribut
field
vaccinolog
complementari
field
edit
acvr
wellillustr
breadth
state
art
field
vaccinolog
well
cut
edg
scienc
address
problem
prevent
develop
safe
effect
vaccin
varieti
pathogen
diseas
six
invit
symposia
topic
includ
special
section
vaccin
includ
articl
base
subset
invit
present
confer
cover
wide
diverg
theme
within
vaccinolog
dr
christoph
broder
et
al
assembl
overview
epidemiolog
rational
current
statu
nipahhendra
viru
anim
vaccin
includ
descript
pioneer
work
lab
develop
highli
effect
subunit
vaccin
base
surfac
glycoprotein
well
promis
monoclon
antibodi
protein
could
use
passiv
transfer
immunoprophylaxi
dr
barney
graham
provid
comprehens
summari
new
gener
vaccin
respiratori
syncyti
viru
major
childhood
ill
vaccin
develop
proven
challeng
part
review
field
also
summar
groundbreak
work
group
nih
vaccin
research
center
elucid
protect
immun
respons
rsv
surfac
fusion
f
glycoprotein
well
gener
solubl
molecularli
stabil
prefus
form
protein
dr
clifford
snapper
highlight
work
two
decad
research
effort
lab
deciph
immun
respons
pneumonia
capsular
polysaccharid
includ
descript
critic
determin
requir
induct
antipolysaccharid
antibodi
final
dr
peter
hotez
colleagu
detail
impetu
rational
vaccin
control
infect
helminth
develop
world
major
caus
disabl
despair
popul
pathogen
endem
